BioCentury
ARTICLE | Company News

AMEV, Centocor antibody deal

May 8, 2002 7:00 AM UTC

Applied Molecular Evolution (AMEV) and Johnson & Johnson (JNJ) subsidiary Centocor (Malvern, Penn.) will use AMEV's AMEsystem technology to optimize the function of an undisclosed Centocor antibody. A...